Idera Pharmaceuticals Inc (NASDAQ:IDRA)’s shares decreased 7.30% to $4.19. The company on Mar. 13 reported its financial and operational results for the fourth quarter and year ended December 31, 2013. Net loss applicable to common stockholders for the three months ended December 31, 2013 was $6.4 million, or $0.10 per diluted share, compared to a net loss applicable to common stockholders of $6.5 million, or $0.24 per diluted share, for the same period in 2012. Idera Pharmaceuticals Inc (NASDAQ:IDRA) shares after opening at $4.15 moved to $ 4.22 on last trade day and at the end of the day closed at $3.88. Company price to sales ratio in past twelve months was calculated as 3774.33 and price to cash ratio as 4.58. Idera Pharmaceuticals Inc (NASDAQ:IDRA) showed a negative weekly performance of -40.12%.
Advaxis, Inc. (Nasdaq: ADXS) announced the pricing of an underwritten public offering of 4,080,000 shares of common stock at a public offering price of $3.00 per share. The Company expects to receive $12,240,000 in gross proceeds, before deducting underwriting discounts and commissions and offering expenses payable by the Company. Advaxis, Inc. (NASDAQ:ADXS) shares fell -24.82% in last trading session and ended the day on $3.06. ADXS return on equity ratio is recorded as -400.00% and its return on assets is -154.60%.
Endocyte, Inc. (NASDAQ:ECYT)‘s stock had its “outperform” rating reiterated by research analysts at Wedbush in a report released on Tuesday, AnalystRatings.Net reports. Endocyte, Inc. (NASDAQ:ECYT) shares moved down -8.33% in last trading session and was closed at $23.07, while trading in range of $22.40 – 25.00 . Endocyte, Inc. (NASDAQ:ECYT) year to date (YTD) performance is 116.01%.
MediWound Ltd. (NASDAQ: MDWD) priced its initial public offering of 5,000,000 ordinary shares at a price to the public of $14 per share, the low end of the expected $14-$16 range. The shares are expected to begin trading on The NASDAQ Global Market under the symbol “MDWD.” Mediwound Ltd (NASDAQ:MDWD) weekly performance is -16.16%. On last trading day company shares ended up $14.48. Mediwound Ltd (NASDAQ:MDWD) distance from 50-day simple moving average (SMA50) is -15.24%.